| A Study of TH-SC01 for Treating Complex Perianal Fistula in Perianal Crohn's Disease. (NCT04939337) | Jinling Hospital, China | 2020-11-12 |
| Drug-Drug Interaction of Pyrotinib With a Moderate CYP3A Inducer (NCT04680091) | Jiangsu HengRui Medicine Co., Ltd. | 2020-11-12 |
| Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity (NCT04715750) | Life Molecular Imaging GmbH | 2020-11-12 |
| Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (NCT04644068) | AstraZeneca | 2020-11-12 |
| Pharmacokinetics of PN-235 in Healthy Volunteers (NCT04621630) | Protagonist Therapeutics, Inc. | 2020-11-12 |
| A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer (NCT04644770) | Janssen Research & Development, LLC | 2020-11-12 |
| Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. (NCT04223765) | UNC Lineberger Comprehensive Cancer Center | 2020-11-12 |
| TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy (NCT04596033) | Genocea Biosciences, Inc. | 2020-11-11 |
| Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers (NCT04611932) | Chong Kun Dang Pharmaceutical | 2020-11-11 |
| A Safety and Tolerability Study of FCN-207 in Healthy Volunteers (NCT04622124) | Fochon Pharmaceuticals, Ltd. | 2020-11-11 |
| A Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Forimtamig in Participants With Relapsed or Refractory Multiple Myeloma (r/r MM) (NCT04557150) | Hoffmann-La Roche | 2020-11-11 |
| Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma (NCT03929029) | Dana-Farber Cancer Institute | 2020-11-11 |
| A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas (NCT04464798) | Celgene | 2020-11-11 |
| Weekly Isotretinoin Therapy Study (NCT04594759) | Medical University of South Carolina | 2020-11-11 |
| Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male Volunteers (NCT04616742) | Jiangsu HengRui Medicine Co., Ltd. | 2020-11-11 |
| PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis (NCT04000906) | University Hospital, Geneva | 2020-11-11 |
| Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis (NCT04454658) | AbbVie | 2020-11-11 |
| Desidustat in the Treatment of Chemotherapy Induced Anemia (NCT04667533) | Zydus Lifesciences Limited | 2020-11-11 |
| Interactions Between Cannabinoids and Cytochrome P450-Metabolized Drugs (NCT04201197) | Johns Hopkins University | 2020-11-10 |
| ALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and Tolerability (NCT04561245) | Altimmune, Inc. | 2020-11-10 |
| Monitored Anesthesia Care: Dexmedetomidine-Ketamine Versus Dexmedetomidine- Propofol For Chronic Subdural Hematoma (NCT04621526) | Zagazig University | 2020-11-10 |
| Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants (NCT04212091) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-11-10 |
| Drug-drug Interaction Study of KL1333 in Healthy Subjects (NCT04643249) | Abliva AB | 2020-11-10 |
| A Study of the Effects of Pirtobrutinib (LOXO-305) on Repaglinide (CYP2C8 Substrate) in Healthy Participants (NCT06165146) | Eli Lilly and Company | 2020-11-10 |
| Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study) (NCT04585815) | Pfizer | 2020-11-10 |
| A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies (NCT04606381) | Janssen Research & Development, LLC | 2020-11-10 |
| Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC) (NCT04543994) | The Cleveland Clinic | 2020-11-10 |
| Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants (NCT04607408) | HIV Vaccine Trials Network | 2020-11-10 |
| A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors (NCT04606472) | Sichuan Baili Pharmaceutical Co., Ltd. | 2020-11-10 |
| A Study To Asses Mass Balance And Absolute Bioavailability Of 14C PF-06826647 In Healthy Male Participants (NCT04591262) | Pfizer | 2020-11-10 |
| A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors (NCT04682431) | Ikena Oncology | 2020-11-10 |
| A Phase I Study of LY-CovMab Injection in Chinese Healthy Subjects (NCT04973735) | Luye Pharma Group Ltd. | 2020-11-10 |
| A Phase 1 (First in Human) Randomized, Double-blind, Placebo-controlled SAD, MAD Study With Oral REM0046127 (NCT04672135) | reMYND | 2020-11-09 |
| Alcohol and Cigarette Craving During Oxytocin Treatment (NCT04071119) | Brown University | 2020-11-09 |
| INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study (NCT04505566) | Stephen J. Kim, MD | 2020-11-09 |
| Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects (NCT04542252) | SymBio Pharmaceuticals | 2020-11-09 |
| A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19 (NCT04582318) | NGM Biopharmaceuticals, Inc | 2020-11-09 |
| A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma (NCT04238819) | Eli Lilly and Company | 2020-11-09 |
| Camu Camu in ART-treated People Living with HIV (NCT04058392) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2020-11-09 |
| A Study of the Pharmacokinetics of ASC09F in Healthy Subjects (NCT04547894) | Ascletis Pharmaceuticals Co., Ltd. | 2020-11-09 |
| Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes (NCT04625595) | Immunomolecular Therapeutics, Inc. | 2020-11-09 |
| Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN) (NCT04408625) | Prevail Therapeutics | 2020-11-09 |
| Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Male Subjects (NCT04636983) | BioVersys SAS | 2020-11-09 |
| Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device (NCT04631354) | Shionogi | 2020-11-09 |
| Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer (NCT04651127) | Sun Yat-sen University | 2020-11-09 |
| A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes Mellitus (NCT04655690) | Novo Nordisk A/S | 2020-11-09 |
| Effect of Therapeutic and Supratherapeutic Oral Doses of GSK3640254 on Cardiac Conduction Compared to Placebo and a Single Oral Dose of Moxifloxacin (NCT04563845) | ViiV Healthcare | 2020-11-09 |
| Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy (NCT04417088) | InSightec | 2020-11-06 |
| The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies (NCT04329728) | AVM Biotechnology Inc | 2020-11-06 |
| Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis (NCT04602390) | Anokion SA | 2020-11-06 |
| A Study to Evaluate How Well Single and Multiple Doses of GLPG4399 Are Tolerated in Healthy, Adult Subjects (NCT04653467) | Lakefront Biotherapeutics NV | 2020-11-06 |
| A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients (NCT04483947) | AstraZeneca | 2020-11-06 |
| A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects (NCT04651036) | Qilu Pharmaceutical Co., Ltd. | 2020-11-06 |
| Vyxeos® With Clofarabine for Pediatric AML (NCT07156435) | Princess Maxima Center for Pediatric Oncology | 2020-11-06 |
| The Study of Drug SCT510A in Patients With Wet Age-related Macular Degeneration (wAMD) (NCT04564937) | Sinocelltech Ltd. | 2020-11-06 |
| A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects (NCT04557280) | Viatris Innovation GmbH | 2020-11-06 |
| A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (NCT04194554) | University of Michigan Rogel Cancer Center | 2020-11-06 |
| Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC (NCT04691947) | Health Institutes of Turkey | 2020-11-05 |
| Single-Dose Islatravir in Moderate Hepatic Impairment (MK-8591-030) (NCT04515641) | Merck Sharp & Dohme LLC | 2020-11-05 |
| A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies (NCT04072458) | Bio-Path Holdings, Inc. | 2020-11-05 |
| Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers (NCT04092179) | University Health Network, Toronto | 2020-11-05 |
| Study to Determine Recommended Phase 2 Dose of Intravenous (IV) Eftozanermin Alfa in Combination With IV or Subcutaneous (SC) Bortezomib and Oral Dexamethasone Tablet and to Assess Change in Disease Symptoms in Adult Participants With Relapsed or Refractory Multiple Myeloma (NCT04570631) | AbbVie | 2020-11-05 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM) (NCT04601051) | Intellia Therapeutics | 2020-11-05 |
| A Study to Evaluate the Safety and Tolerability of EXN407 (NCT04565756) | Exonate Limited | 2020-11-05 |
| Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses (NCT06171607) | University of Southern California | 2020-11-05 |
| CBD Effects on Periodontal Health of Patients With Chronic Periodontitis (NCT05498012) | Palacky University | 2020-11-05 |
| Behavioral Pharmacology of THC and Alpha-pinene (NCT04130633) | Johns Hopkins University | 2020-11-05 |
| Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects (NCT04783753) | Enanta Pharmaceuticals, Inc | 2020-11-05 |
| Effect of Perampanel on Peritumoral Hyperexcitability in HGG (NCT04497142) | Dana-Farber Cancer Institute | 2020-11-05 |
| Hyperpolarized Xenon-129 MR Imaging of the Lung (NCT04662658) | University of Virginia | 2020-11-05 |
| Bioequivalence Study of Ciprofloxacin in Healthy Adult Subjects Under Fasting Condition (NCT05532267) | Future University in Egypt | 2020-11-04 |
| Anti-SARS Cov-2 T Cell Infusions for COVID 19 (NCT04401410) | Baylor College of Medicine | 2020-11-04 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole (NCT04604795) | GlaxoSmithKline | 2020-11-04 |
| Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia (NCT04661644) | S.Biomedics Co., Ltd. | 2020-11-04 |
| A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420. (NCT04580121) | Hoffmann-La Roche | 2020-11-04 |
| Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis (NCT04548583) | The Cleveland Clinic | 2020-11-04 |
| Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old (NCT04687761) | PETHEMA Foundation | 2020-11-04 |
| Safety and Tolerability of SYNB8802 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria (NCT04629170) | Synlogic | 2020-11-04 |
| Using Vedolizumab-800CW to Gain Insight Into Local Drug Distribution and Mucosal Target Cells in IBD Patients (NCT04112212) | University Medical Center Groningen | 2020-11-04 |
| STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY (NCT04616339) | Pfizer | 2020-11-04 |
| Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia (NCT04606433) | Sichuan Baili Pharmaceutical Co., Ltd. | 2020-11-04 |
| Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants (NCT04608344) | Gilead Sciences | 2020-11-04 |
| Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX14 Versus Prolia® in Healthy Male Subjects (NCT04534582) | Shanghai Henlius Biotech | 2020-11-03 |
| Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL) (NCT04663347) | Genmab | 2020-11-03 |
| Pharmacokinetic Study of DARE-BV1 (NCT05354050) | Daré Bioscience, Inc. | 2020-11-03 |
| A Study Of The Pharmacokinetics And Safety Of Ipatasertib In Chinese Participants With Locally Advanced Or Metastatic Solid Tumors. (NCT04341259) | Hoffmann-La Roche | 2020-11-03 |
| Bemotrizinol UV Filter Part 1 Clinical PK Evaluation in Topical MUsT Study (NCT04355286) | dsm-firmenich Switzerland AG | 2020-11-03 |
| Cemiplimab in AlloSCT/SOT Recipients With CSCC (NCT04339062) | Dana-Farber Cancer Institute | 2020-11-03 |
| Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch (NCT04624867) | Noven Pharmaceuticals, Inc. | 2020-11-03 |
| Phase 1b Study to Assess Safety, Tolerability, and Pharmacokinetics of ARCT-810 in Stable Adult Subjects With Ornithine Transcarbamylase Deficiency (NCT04442347) | Arcturus Therapeutics, Inc. | 2020-11-03 |
| Phase I Clinical Study of SPH4336 Tablets in the Treatment of Advanced Solid Tumors (NCT05905614) | Shanghai Pharmaceuticals Holding Co., Ltd | 2020-11-03 |
| To Evaluate the Pharmacokinetic Interactions and Safety in Healthy Volunteers (NCT05351840) | JW Pharmaceutical | 2020-11-02 |
| Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19 (NCT04334980) | Symvivo Corporation | 2020-11-02 |
| FX-322 in Adults With Severe Sensorineural Hearing Loss (NCT04629664) | Frequency Therapeutics | 2020-11-02 |
| IMP4297 DDI (Drug-Drug Interaction)Trial in Healthy Male Volunteers (NCT04584515) | Impact Therapeutics, Inc. | 2020-11-02 |
| Study of AT-527 in Healthy Subjects (R07496998) (NCT04711187) | Atea Pharmaceuticals, Inc. | 2020-11-02 |
| Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient (NCT04595136) | United Medical Specialties | 2020-11-02 |
| XZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer (NCT04622072) | Sihuan Pharmaceutical Holdings Group Ltd. | 2020-11-02 |
| A Food Effect Study With ZN-c5 in Healthy Post-Menopausal Subjects (NCT04561752) | Zeno Alpha Inc. | 2020-11-02 |
| A Study of Mirikizumab in Healthy Participants (NCT04607733) | Eli Lilly and Company | 2020-11-02 |